Worldwide Research Trends on Artemisinin: A Bibliometric Analysis From 2000 to 2021

Yankai Dong, Lina Liu, Jie Han, Lianqing Zhang, Yi Wang, Juan Li, Yuexiang Li, He Liu, Kun Zhou, Luyao Li, Xin Wang, Xue Shen, Meiling Zhang, Bo Zhang, Xiaofei HuFrontiers in Medicine 2022 · DOI

TL;DR

This paper provides a comprehensive bibliometric analysis of research on artemisinin from 2000 to 2021, revealing a significant increase in publications and identifying key trends, leading countries, institutions, and research hotspots. It highlights the growing importance of artemisinin resistance mechanisms, combination therapies, and its emerging role in treating COVID-19.

What Problem Does This Paper Address?

Artemisinin, a crucial antimalarial compound derived from Artemisia annua, has been the cornerstone of malaria treatment for decades. However, the emergence of artemisinin resistance in Plasmodium falciparum and the expanding therapeutic applications of artemisinin beyond malaria (e.g., antiviral, antitumor) necessitate a clear understanding of the global research landscape. This paper addresses the need for a comprehensive overview of artemisinin research trends, identifying key areas of focus, influential players, and emerging frontiers to guide future research and development efforts.

Methods

The study employed a bibliometric analysis approach using data from the Web of Science Core Collection (WoSCC) for publications between 2000 and 2021. The retrieved data was analyzed using VOSviewer and Citespace software to visualize research trends, identify hotspots, and map collaborations. Key bibliometric indicators such as the number of publications (NPs), citations (NC), H-index, and average citations per publication were extracted and analyzed. Co-occurrence network analysis was used to identify keyword clusters and research themes.

Datasets

The study utilized publications and their associated metadata retrieved from the Web of Science Core Collection (WoSCC). The dataset comprised 8,466 articles and reviews published between 2000 and 2021. The analysis focused on English-language publications, excluding various document types like meeting abstracts, book chapters, and letters.

Key Insights and Ideas

  • Artemisinin's Expanding Role: While malaria remains a primary focus, research is increasingly exploring artemisinin's potential in other areas, including antiviral, antitumor, and anti-inflammatory applications.
  • The Rise of Resistance: The emergence and spread of artemisinin resistance in Plasmodium falciparum is a significant and growing concern, driving substantial research into resistance mechanisms and molecular markers.
  • COVID-19 as a New Frontier: The study identified a nascent but growing body of research investigating artemisinin's therapeutic potential against COVID-19, highlighting its anti-inflammatory and antiviral properties.
  • Global Collaboration is Key: While the United States and China are leading in publication output, effective international collaboration is crucial for advancing artemisinin research.
  • Quality vs. Quantity: While some countries lead in publication numbers, others demonstrate higher quality research as indicated by average citations per item, suggesting a need for quality improvement in certain regions.

Key Results

  • A total of 8,466 publications were retrieved, with a steady increase in annual publications from 2000 to 2021, peaking in 2020.
  • The United States published the most papers (2,050) and had the highest number of citations (76,901) and H-index (131).
  • China ranked second in publications (1,641) but lagged behind England and Thailand in terms of average citations per item, suggesting room for improvement in research quality.
  • The University of Oxford and Mahidol University were the most productive affiliations.
  • MALARIA JOURNAL was the most productive journal, though its impact factor was relatively low compared to other high-impact journals that published significant findings.
  • Key research hotspots included artemisinin resistance, molecular markers, polymorphisms, and drug discovery.
  • The biosynthesis, drug resistance mechanisms, and combination therapies involving artemisinin have become increasingly popular research areas.

Limitations and Future Work

The authors acknowledge several limitations:

  • The study was limited to English-language publications from WoSCC, potentially excluding valuable research from other languages.
  • The analysis did not include full-text content, which might lead to the omission of some nuanced information.
  • The exclusion of recent publications might result in a slight lag in reflecting the very latest trends.

Future work should focus on:

  • Investigating the mechanisms of artemisinin resistance in Africa, which may differ from those observed in Cambodia.
  • Exploring the combination of artemisinin with other drugs and developing novel artemisinin compound drugs to combat resistance.
  • Further research into the clinical safety and effectiveness of artemisinin for treating COVID-19, building on promising preliminary findings.
  • Expanding research on the antibacterial properties of artemisinin, which is currently in its early stages.
  • Improving the quality of publications from certain countries to enhance their global impact.

Summary updated

Abstract

The biosynthesis, drug resistance mechanism, and combination of artemisinin have become more popular than before. Studies on artemisinin treating coronavirus disease 2019 (COVID-19) have been carried out, and good research results have been obtained.
BibTeX
@inproceedings{dong2022worldwide,
  author = {Yankai Dong and Lina Liu and Jie Han and Lianqing Zhang and Yi Wang and Juan Li and Yuexiang Li and He Liu and Kun Zhou and Luyao Li and Xin Wang and Xue Shen and Meiling Zhang and Bo Zhang and Xiaofei Hu},
  title = {{Worldwide Research Trends on Artemisinin: A Bibliometric Analysis From 2000 to 2021}},
  booktitle = {Frontiers in Medicine},
  year = {2022},
  doi = {10.3389/fmed.2022.868087},
}
Figure